June 1, 2005
Tulane University urologists are seeking couples struggling with premature ejaculation for a local study. Over the course of the six-month study, men will be asked to try a series of drug combinations in order to assess the drugs' effectiveness in lengthening sexual performance.
"Premature ejaculation is a quality of life issue," says urologist Wayne Hellstrom, principal investigator. "For couples who are struggling with this problem, it can be a source of great stress and unhappiness. We recognize that this is an issue of concern to both partners, not just the men. With our study, we are trying to explore new medical approaches to managing the problem of premature ejaculation."
According to Hellstrom, premature ejaculation is the most common complaint of sexual dysfunction among men. The causes of the problem vary and it can strike any age and any ethnicity. For the purposes of the study, premature ejaculation is defined as ejaculation within two minutes of vaginal penetration during at least half of all encounters. In order to qualify for the study, couples must be stable, monogamous and together for at least three months.
Both partners must be healthy, between 18 and 60 years old and meet all of the study criteria, based on a free physical examination, blood test and EKG provided by the study team. Couples can not be pregnant or intending to become pregnant during the study. Male participants will be asked to take Levitra, Paxil, a placebo or a combination of Levitra and Paxil before having sexual intercourse. With the help of their partners, they will then time their encounters, keep records at home and make monthly visits to the clinic for medication and study purposes.
The couples' time and effort will be compensated. The study is funded by Vivus, Inc, manufacturer of the erectile dysfunction drug MUSE. Interested couples should call 504.988.1920 to see if they qualify for the six-month study.
Tulane University, New Orleans, LA 70118 504-865-5000 email@example.com